Kirsten A. Porter-Stransky - Publications

Emory University, Atlanta, GA 
dopamine, norepinephrine, reward, addiction, Parkinson's disease, sleep

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D. Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids. Addiction Biology. e12823. PMID 31441201 DOI: 10.1111/adb.12823  1
2019 Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D. Selective D and D receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30879021 DOI: 10.1038/s41386-019-0371-2  1
2018 Porter-Stransky KA, Centanni SW, Karne SL, Odil LM, Fekir S, Wong JC, Jerome C, Mitchell HA, Escayg A, Pedersen NP, Winder DG, Mitrano DA, Weinshenker D. Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal. Biological Psychiatry. PMID 30269865 DOI: 10.1016/j.biopsych.2018.07.027  1
2018 Al-Hasani R, Wong JT, Mabrouk OS, McCall JG, Schmitz GP, Porter-Stransky KA, Aragona BJ, Kennedy RT, Bruchas MR. detection of optically-evoked opioid peptide release. Elife. 7. PMID 30175957 DOI: 10.7554/eLife.36520  0.72
2017 Christopher MA, Myrick DA, Barwick BG, Engstrom AK, Porter-Stransky KA, Boss JM, Weinshenker D, Levey AI, Katz DJ. LSD1 protects against hippocampal and cortical neurodegeneration. Nature Communications. 8: 805. PMID 28993646 DOI: 10.1038/s41467-017-00922-9  1
2017 Porter-Stransky KA, Weinshenker D. Arresting the Development of Addiction: The Role of β-Arrestin2 in Drug Abuse. The Journal of Pharmacology and Experimental Therapeutics. PMID 28302862 DOI: 10.1124/jpet.117.240622  1
2016 Resendez SL, Keyes PC, Day JJ, Hambro C, Austin CJ, Maina FK, Eidson L, Porter-Stransky KA, Nevárez N, McLean JW, Kuhnmuench MA, Murphy AZ, Mathews TA, Aragona BJ. Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds. Elife. 5. PMID 27371827 DOI: 10.7554/eLife.15325  1
2015 Porter-Stransky KA, Bentzley BS, Aston-Jones G. Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil. Addiction Biology. PMID 26598295 DOI: 10.1111/adb.12323  1
2014 Vander Weele CM, Porter-Stransky KA, Mabrouk OS, Lovic V, Singer BF, Kennedy RT, Aragona BJ. Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery. The European Journal of Neuroscience. 40: 3041-54. PMID 25208732 DOI: 10.1111/ejn.12709  1
2013 Porter-Stransky KA, Seiler JL, Day JJ, Aragona BJ. Development of behavioral preferences for the optimal choice following unexpected reward omission is mediated by a reduction of D2-like receptor tone in the nucleus accumbens. The European Journal of Neuroscience. 38: 2572-88. PMID 23692625 DOI: 10.1111/ejn.12253  1
2013 Slaney TR, Mabrouk OS, Porter-Stransky KA, Aragona BJ, Kennedy RT. Chemical gradients within brain extracellular space measured using low flow push-pull perfusion sampling in vivo. Acs Chemical Neuroscience. 4: 321-9. PMID 23421683 DOI: 10.1021/cn300158p  1
2011 Porter-Stransky KA, Wescott SA, Hershman M, Badrinarayan A, Vander Weele CM, Lovic V, Aragona BJ. Cocaine must enter the brain to evoke unconditioned dopamine release within the nucleus accumbens shell. Neuroscience Letters. 504: 13-7. PMID 21888949 DOI: 10.1016/j.neulet.2011.08.028  1
Show low-probability matches.